- Home
- BLCO vs EXEEZ Comparison
BLCO vs EXEEZ Comparison
Compare BLCO & EXEEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- EXEEZ
- Stock Information
- Founded
- BLCO 1853
- EXEEZ N/A
- Country
- BLCO Canada
- EXEEZ United States
- Employees
- BLCO N/A
- EXEEZ N/A
- Industry
- BLCO Ophthalmic Goods
- EXEEZ Oil & Gas Production
- Sector
- BLCO Health Care
- EXEEZ Energy
- Exchange
- BLCO Nasdaq
- EXEEZ Nasdaq
- Market Cap
- BLCO 7.0B
- EXEEZ 8.4B
- IPO Year
- BLCO 2022
- EXEEZ N/A
- Fundamental
- Price
- BLCO $19.58
- EXEEZ $85.22
- Analyst Decision
- BLCO Buy
- EXEEZ
- Analyst Count
- BLCO 11
- EXEEZ 0
- Target Price
- BLCO $21.30
- EXEEZ N/A
- AVG Volume (30 Days)
- BLCO 442.8K
- EXEEZ N/A
- Earning Date
- BLCO 10-30-2024
- EXEEZ N/A
- Dividend Yield
- BLCO N/A
- EXEEZ N/A
- EPS Growth
- BLCO N/A
- EXEEZ N/A
- EPS
- BLCO N/A
- EXEEZ N/A
- Revenue
- BLCO $4,684,000,000.00
- EXEEZ N/A
- Revenue This Year
- BLCO $17.44
- EXEEZ N/A
- Revenue Next Year
- BLCO $6.18
- EXEEZ N/A
- P/E Ratio
- BLCO N/A
- EXEEZ N/A
- Revenue Growth
- BLCO 18.01
- EXEEZ N/A
- 52 Week Low
- BLCO $13.16
- EXEEZ N/A
- 52 Week High
- BLCO $21.69
- EXEEZ N/A
- Technical
- Relative Strength Index (RSI)
- BLCO 47.50
- EXEEZ N/A
- Support Level
- BLCO $19.31
- EXEEZ N/A
- Resistance Level
- BLCO $20.23
- EXEEZ N/A
- Average True Range (ATR)
- BLCO 0.48
- EXEEZ 0.00
- MACD
- BLCO -0.10
- EXEEZ 0.00
- Stochastic Oscillator
- BLCO 19.37
- EXEEZ 0.00
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.